NexEos Bio
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
640 Lee Rd Ste 115, Wayne, Pennsylvania,...Phone Number
(610) 457-9891Website
www.nexeosbio.comRevenue
<$5 MillionIndustry
About NexEos Bio
NexEos Bio is dedicated to developing innovative technologies for the identification and treatment of eosinophil and cationic protein-mediated inflammation. Their lead programs include NTX-1024, a topical ophthalmic solution for eosinophil-driven ocular diseases, and NDX-3324, a non-invasive imaging agent for diagnosing and managing Eosinophilic Esophagitis (EoE). The company aims to provide better solutions for patients suffering from debilitating diseases, enhancing their quality of life and slowing disease progression. NexEos Bio serves patients in need of advanced diagnostic and therapeutic options for eosinophil-related conditions.Explore more
SIC Code 28,283NAICS Code 32,325Show moreNexEos Bio Org Chart
NexEos Bio Tech Stack
A closer look at the technologies used by NexEos Bio
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NexEos Bio
Sign Up For FreeTo access detailed company insights
NexEos Bio is dedicated to developing innovative technologies for the identification and treatment of eosinophil and cationic protein-mediated inflammation. Their lead programs include NTX-1024, a topical ophthalmic solution for eosinophil-driven ocular diseases, and NDX-3324, a non-invasive imaging agent for diagnosing and managing Eosinophilic Es... Read More